CenterWatch

Macular Degeneration Clinical Trials

A listing of Macular Degeneration medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Arizona

UPDATED

Phoenix Arizona

A clinical research study of X-82, Aflibercept and Placebo

Gilbert Arizona 85295

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Gilbert Arizona 85296

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Mesa Arizona 85210

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Peoria Arizona 85381

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

View More ▼

Phoenix Arizona 85014

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

Phoenix Arizona 85014

A clinical research study of Fovista®, Bevacizumab, Ranibizumab and Aflibercept for the treatment of Age-Related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Phoenix Arizona 85014

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Tucson Arizona 85704

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Tucson Arizona 85710

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

California

UPDATED

Beverly Hills California

A clinical research study of X-82, Aflibercept and Placebo

Bakersfield California 93309

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

Bakersfield California 93309

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Beverly Hills California 90211

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

Beverly Hills California 90211

A clinical research study of Fovista®, Bevacizumab, Ranibizumab and Aflibercept for the treatment of Age-Related Macular Degeneration

View More ▼

Beverly Hills California 90211

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Beverly Hills California

A Phase 1 clinical study for patients with Neovascular Age-Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)

Beverly Hills California

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Beverly Hills California 90211

Patients are needed to participate in a clinical research study of X-82 oral and ranibizumab (Lucentis) to evaluate Exudative Macular Degeneration

Campbell California 95008

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Fresno California 93720

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Fullerton California 92835

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Fullerton California 92835

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Irvine California 92697

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

La Jolla California 92093

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

La Jolla California 92093

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Loma Linda California 92354

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Los Angeles California 90095

A clinical research study of Microplasmin and Placebo control for the treatment of Macular Degeneration

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Dry Age Related Macular Degeneration

Los Angeles California 90095

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Los Angeles California 90095

A clinical trial to evaluate treatments using MA09-hRPE Cellular therapy for patients with Stargardt's Macular Dystrophy

Los Angeles California 90095-7000

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Los Angeles California 90095-7000

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Marietta California 30060

A clinical trial to evaluate treatments using pegaptanib sodium injection for patients with Age-Related Macular Degeneration, Retinal Vein Occlusion or Diabetic Macular Edema

Mountain View California 94040

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Mountain View California 94040

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Mountain View California 94040

Patients are needed to participate in a clinical research study evaluating Ranibizumab for the treatment of Recalcitrant Wet Age-related Macular Degeneration

Oakland California 94609

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Palm Desert California 92211

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Palm Desert California 92211

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Poway California 92064

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Sacramento California 95841

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

Sacramento California 95819

A clinical research study of Fovista® (anti-PDGF BB) plus anti-VEGF for the treatment of Age-related Macular Degeneration

Sacramento California 95819

A clinical research study of Fovista®, Bevacizumab, Ranibizumab and Aflibercept for the treatment of Age-Related Macular Degeneration

Sacramento California 95841

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Sacramento California 95819

A Phase 3 clinical study for patients with Age-Related Macular Degeneration

Sacramento California 95819

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy